Astrazeneca plc ADR (NASDAQ:AZN) price closed higher on Tuesday,December 03, and jumping 1.51% above its previous close.
A look at the daily price movement shows that the last close reads $67.04, with intraday deals fluctuated between $68.0 and $68.65. The company’s 5Y monthly beta was ticking 0.18 while its P/E ratio in the trailing 12-month period read 32.70. Taking into account the 52-week price action we note that the stock hit a 52-week high of $87.68 and 52-week low of $60.47. The stock subtracted -4.72% on its value in the past month.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Astrazeneca plc ADR, which has a market valuation of $211.00 billion, is expected to release its quarterly earnings report in January. The company stock has a Forward Dividend ratio of 1.49, while the dividend yield is 2.18%. It is understandable that investor optimism is growing ahead of the company’s current quarter results.
On average, analysts have forecast the company’s revenue for the quarter will hit 14.14B, with the likely lows of 13.58B and highs of 14.64B. The average estimate suggests sales growth for the quarter will likely rise by 17.56% when compared to those recorded in the same quarter in the last financial year. Staying with the analyst view, there is a consensus estimate of 53.03B for the company’s annual revenue in current year. Per this projection, the revenue is forecast to grow 15.77% above that which the company brought in the current year earning report.
Technical indicators in stocks provide crucial insights into market trends, guiding investors with precise entry and exit points based on price movements for informed decision-making.On the technical perspective front, indicators give AZN a short term outlook of 50% Sell on average. Looking at the stock’s medium term indicators we note that it is averaging as a 100% Sell, while an average of long term indicators are currently assigning the stock as 50% Sell.
Here is a look at the average analyst rating for the stock as represented on a scale of 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock is strong buy or strong sell respectively. Specifically, 10 analysts have assigned AZN a recommendation rating as follows: 2 rate it as a Hold; 8 advise Buy while 0 analyst(s) assign an Overweight rating. 0 analyst(s) have tagged the Astrazeneca plc ADR (AZN) stock as Underweight, with 0 recommending Sell. In general, analysts have rated the stock Buy, a scenario likely to bolster investors out for an opportunity to add to their holdings of the company’s shares.
If we dive deeper into the stock’s performance we see the positive picture represented by the PEG ratio, currently standing at 2.73. The overview shows that AZN’s price is at present 4.23% off the SMA20 and -5.60% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 49.92, with weekly volatility standing at 1.09%. The indicator jumps to 1.73% when calculated based on the past 30 days. Astrazeneca plc ADR (NASDAQ:AZN)’s beta value is holding at 0.46, while the average true range (ATR) indicator is currently reading 1.32. Considering analysts have assigned the stock a price target range of $79-$88 as the low and high respectively, we find the trailing 12-month average consensus price target to be $85. Based on this estimate, we see that current price is roughly -16.09% off the estimated low and -29.32% off the forecast high. Investors will no doubt be excited to see the share price fall to $85, which is the median consensus price, and at that level AZN would be -24.91% from current price.
An analysis of the Astrazeneca plc ADR (NASDAQ:AZN) stock in terms of its daily trading volume indicates that the 3-month average is 5.45 million. However, this figure increases on the past 10-day timeline to an average of 6.04 million.
Current records show that the company has 3.10B in outstanding shares. The percentage share held by institutions stands at 15.79%. The stats also highlight that short interest as of 2024-11-15, stood at 8.07 million shares, which puts the short ratio at the time at 1.23. From this we can glean that short interest is 26.00 of company’s current outstanding shares. Notably, we see that shares short in November rose slightly given the previous month’s figure stood at 4.03 million. But the 1.04% upside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
